NEW YORK (GenomeWeb News) – Waters has entered into a new credit agreement to provide the company $1.4 billion in debt financing.

In a document filed today with the US Securities and Exchange Commission, Waters said that the credit agreement, dated June 25, is with JP Morgan Chase Bank as administrative agent and JP Morgan Europe as London agent. It provides Waters with a five-year unsecured $300 million term loan facility and a $1.1 billion revolving facility, which includes a letter of credit and a swingline subfacility.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Cell this week: map of human protein interactions, mutant phenotype variability in organisms of the same species from different genetic backgrounds, and more.

Critics call the Fred Hutchinson Cancer Research Center's Gary Gilliland's prediction of cancer cures within 10 years "out of touch with reality" and "irresponsible."

Ivan Oransky discusses the need for reproducibility research at The Conversation.

The San Diego Union-Tribune posts videos from Biocom's Speaker Series with Illumina's Jay Flatley, who discusses Roche's failed hostile takeover bid.